España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Lucid Diagnostics
LUCD
NASDAQ
Watchlist
Get Report
Perks
Buy
Compare Brokers
$0.860000
-0.02
-2.29%
Pre-Market: 6:07 PM EDT
15 minutes delayed
Get Report
Watch
Lucid Diagnostics (LUCD) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Lucid Diagnostics (NASDAQ:LUCD) Stock
Lucid Diagnostics Stock (NASDAQ: LUCD)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, July 02, 2024
Lucid Diagnostics shares are trading higher a...
Benzinga Newsdesk
Lucid Diagnostics Announces Data From ESOGUAR...
Benzinga Newsdesk
Wednesday, June 12, 2024
Lucid Diagnostic Reports 4,000 Firefighter Un...
Benzinga Newsdesk
Thursday, June 06, 2024
Ascendiant Capital Maintains Buy on Lucid Dia...
Benzinga Newsdesk
Wednesday, May 15, 2024
Cantor Fitzgerald Reiterates Overweight on Lu...
Benzinga Newsdesk
Monday, May 13, 2024
Needham Reiterates Buy on Lucid Diagnostics, ...
Benzinga Newsdesk
Lucid's Chairman And CEO Says We Strengthened...
Benzinga Newsdesk
Lucid Diagnostics Q1 2024 Adj EPS $(0.21) Bea...
Benzinga Newsdesk
Thursday, May 09, 2024
Lucid Diagnostics Says EsophaCap Device Recal...
Benzinga Newsdesk
Thursday, May 02, 2024
Lucid Diagnostics Announces Peer-Reviewed Pub...
Benzinga Newsdesk
Tuesday, April 30, 2024
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Monday, April 29, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Friday, April 12, 2024
Needham Reiterates Buy on Lucid Diagnostics, ...
Benzinga Newsdesk
Wednesday, March 27, 2024
Cantor Fitzgerald Maintains Overweight on Luc...
Benzinga Newsdesk
Needham Reiterates Buy on Lucid Diagnostics, ...
Benzinga Newsdesk
Monday, March 25, 2024
Lucid Diagnostics Q4 EPS $(0.23) Beats $(0.26) Estimate, Sales $1.04M Miss $1.05M Estimate
Happy Mohamed
Lucid Diagnostics Provides Business Update; R...
Benzinga Newsdesk
Earnings Scheduled For March 25, 2024
Benzinga Insights
Friday, March 22, 2024
Earnings Preview: Lucid Diagnostics
Benzinga Insights
Thursday, March 21, 2024
Lucid Diagnostics Announces Data From The Fir...
Benzinga Newsdesk
Wednesday, March 20, 2024
Lucid Diagnostics Announces Multiple Presenta...
Benzinga Newsdesk
Monday, February 19, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Thursday, January 18, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Tuesday, December 12, 2023
Lucid Diagnostics Announces Peer-Reviewed Pub...
Benzinga Newsdesk
Monday, December 11, 2023
PAVmed Provides Additional Details For Upcomi...
Benzinga Newsdesk
Monday, December 04, 2023
PAVmed Shareholders As Of January 15, 2024 Wi...
Benzinga Newsdesk
Tuesday, November 28, 2023
On November 27, 2023, Lucid Diagnostics Recei...
Benzinga Newsdesk
Thursday, November 16, 2023
Lucid Diagnostics Strengthens And Expands Mar...
Benzinga Newsdesk
Tuesday, November 14, 2023
Needham Maintains Buy on Lucid Diagnostics, L...
Benzinga Newsdesk
Monday, November 13, 2023
Lucid Diagnostics Q3 Adj EPS $(0.22) Beats $(...
Benzinga Newsdesk
Lucid Diagnostics Q3 EPS $(0.22) Beats $(0.27...
Benzinga Newsdesk
Lucid Diagnostics Reports Q3 EsoGuard Revenue...
Benzinga Newsdesk
Earnings Scheduled For November 13, 2023
Benzinga Insights
Friday, November 10, 2023
Earnings Preview For Lucid Diagnostics
Benzinga Insights
Tuesday, September 26, 2023
Cantor Fitzgerald Reiterates Overweight on Lu...
Benzinga Newsdesk
Thursday, September 07, 2023
Lucid Diagnostics Releases Positive Data From...
Benzinga Newsdesk
Wednesday, September 06, 2023
Lucid Diagnostics Releases Data Demonstrating Clinical Utility Of EsoGuard Esophageal Precancer Detection In Fire Fighters
Happy Mohamed
Thursday, August 24, 2023
Lucid Diagnostics Executes First Direct Employer Contract To Provide Ancira Auto Group EsoGuard Esophageal Precancer Testing As An Employee Benefit
Happy Mohamed
Tuesday, August 22, 2023
Cantor Fitzgerald Reiterates Overweight on Lu...
Benzinga Newsdesk
Wednesday, August 16, 2023
Cantor Fitzgerald Reiterates Overweight on Lu...
Benzinga Newsdesk
Monday, August 14, 2023
Lucid Diagnostics Q2 EPS $(0.27) Beats $(0.32...
Benzinga Newsdesk
Earnings Scheduled For August 14, 2023
Benzinga Insights
Wednesday, July 19, 2023
PAVmed And Lucid Chairman And Chief Executive Officer, Dr. Lishan Aklog, Testifies At U.S. House Of Representatives Energy And Commerce Committee, Hearing On Life-Saving Innovations And Medicare Coverage
Happy Mohamed
Monday, June 05, 2023
Lucid Diagnostics Launches EsoGuard Mobile Te...
Benzinga Newsdesk
Wednesday, May 17, 2023
Where Lucid Diagnostics Stands With Analysts
Benzinga Insights
Cantor Fitzgerald Maintains Overweight on Luc...
Benzinga Newsdesk
Needham Maintains Buy on Lucid Diagnostics, R...
Benzinga Newsdesk
Tuesday, May 16, 2023
Lucid Diagnostics Q1 EPS $(0.40) Misses $(0.35) Estimate, Sales $446.00K Beat $220.00K Estimate
Happy Mohamed
Monday, May 15, 2023
Earnings Scheduled For May 15, 2023
Benzinga Insights
Friday, May 12, 2023
Preview: Lucid Diagnostics's Earnings
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
